REMOVE THE PAIN - UNLEASH THE POSSIBILITIES! Pain Relief International, a registered 501(c)(3) non-profit and global leader in sustainable, drug-free pain relief technology, is proud to announce its commitment to delivering life-changing pain relief to millions of Australians suffering from chronic conditions, including migraine headaches, menstrual pain, back pain, and more.
PayToMe.co, an award-winning AI-driven fintech marketplace and top 1% global startup through Startupbootcamp, has announced an innovative partnership with Boundarie.
GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine in older adults.
Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly presented study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) in a safety analysis of Anti-Xa and the VCM.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman's Address to be provided by Mr Neville Gardiner and the Investor Presentation to be provided by Dr Richard Lipscombe to shareholders.
GenieUs Genomics (“GenieUs”) is excited to provide advanced genomic analysis for Neurizon Therapeutics Limited’s (“Neurizon”; ASX:NUZ; ASX:NUZOA) Phase 1 clinical trial of monepantel, now known as NUZ-001, marking an important step in understanding the genetic landscape of ALS patients.
Cloud Ready Solutions, a leading value-added IT distributor in Australia and the Pacific Islands, has partnered with StoneFly, Inc. (iscsi.com) a global leader in ransomware-proof enterprise storage, HCI, backup and disaster recovery (DR), cloud, and AI solutions.
